Bonista PF 250MCG Injection (2.4ml) is a pharmaceutical product that contains Teriparatide, a synthetic form of parathyroid hormone, at a concentration of 250mcg/ml. This medication is primarily used in the treatment of osteoporosis, particularly in postmenopausal women and men at high risk of fractures. By stimulating bone formation, Bonista PF helps to increase bone mineral density and reduce the risk of fractures, making it a vital option for individuals with weakened bones. The injection is typically administered subcutaneously, allowing for effective absorption and action within the body. As a crucial component in managing osteoporosis, Bonista PF 250MCG Injection plays a significant role in improving the quality of life for patients suffering from this condition.